Local Institution
Petah Tikva 4941492
0 studies enrolling now · 23 studies all time
What they study most
Acute Coronary Syndrome, Acute Coronary Syndrome (ACS), Atrial Fibrillation, Atrial Flutter, Cancer, Chronic Hepatitis B Virus, Pediatric, Chronic Kidney Failure, Deep Vein Thrombosis, Deep-Vein Thrombosis, Kidney Transplantation, Lung Cancer, Lung Cancer - Non Small Cell Squamous
Studies at this site
- Pan Tumor Rollover Study — Recruiting now
- Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis — Running, not enrolling
- An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma — Completed
- An Investigational Immuno-therapy Study of Nivolumab, or Nivolumab in Combination With Ipilimumab, or Placebo in Patients With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based Chemotherapy — Completed
- An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis — Completed
- An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus — Completed
- Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma — Completed
- A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL) — Completed
- Effects of Abatacept in Patients With Early Rheumatoid Arthritis — Completed
- Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone — Completed
- Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin — Completed
- A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus Infection — Completed
- Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
- A Phase III Study of Apixaban in Patients With Atrial Fibrillation — Completed
- Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT) — Completed
- Phase III Acute Coronary Syndrome — Stopped early
- Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery — Completed
- Safety Study of Apixaban in Recent Acute Coronary Syndrome — Completed
- Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness — Completed
- Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism — Completed
- Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism — Completed
- Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study — Completed
- BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery — Completed